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Pathology, The Aga Khan University Hospital, Karachi. ) 
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Abstract 
Objective: To observe the spectrum of non-Hodkin’s lymphomas involving the central nervous system
including morphological subtypes and immunophenotypic status.
Setting: Retrospective analysis of eleven years (1986 to 1996) data from surgical pathology files of
Department of Pathology.
Results: orty-three cases of non-Hodgkin’s lymphomas were diagnosed during the period of eleven
years (from 1986 to 1996), all of which were diffuse types. A total of 1177 Central Nervous CNS
biopsies were examined, out of which 937 cases were diagnosed as CNS neoplasms, the remaining
were non-neoplastic in nature. Among 937 CNS neoplasms, 43 cases (4.6%) were reported as non-
Hodgkin’s lymphomas. As most of the cases were outside referrals, the primary or secondary nature of
the lymphomatous process could not he assessed. Seventeen cases were intracranial, while 26 cases
were spinal in location. Majority of the intracranial Eymphomas were hiopsied from the cereherum (12
cases). Male to female ratio was 1:2. The median age for intracranial lvmphomas was 50 years and for
spinal lymphomas 29 years. There were 16 cases (37%) of diffuse large cell lymphomas; 7 cases (16%)
of diffuse mixed small and large cell lymphomas; 3 cases (7%) of diffuse large cell immunoblastic
lvmphomas; 2 cases (4.6%) of lymphoblastic lymphomas and diffuse small non-cleaved cell
lymphomas and one case of small Iyrnphocytic lymphoma and diffuse small cleaved cell Ivmphoma.
One case of T cell rich B cell lvmphoma was also diagnosed in the thoracic spine as primary extranodal
lymphoma. Eight cases were unclassifiable and in 2 cases the features were suggestive of lymphoma.
Immunophenotypic analysis was performed in 20 cases, however, in 2 cases the results were
inconclusive. Fifteen cases (83%) showed immunoreactivity for B cell markers and 3 cases showed T
cell phenotype out of which one case was lymphoblastic lymphoma.
Conclusion: CNS lymphomas were uncommon tumors and comprised 4.6% of the total CNS
neoplasms in our study. Moreover, these CNS lymphomas accounted for 2.2% of the total non-
Hodgkin’s lvmphomas, including both nodal and extranodal. There was a higher incidence of location
of these lymphomas within the spinal cord than brain. Most of the lymphomas were of intermediate or
high grade (75%) according to the working phenotype in 84% 3f the lymphomas, in which it was
formulation. lmmunophenotypical status revealed B-cell tested (JPMA 50:141, 2000).
Introduction 
The extra-nodal lymphomas is a group ofi non—Hodgkin’s lymphomas which arise in non—lymphoid
bearing sites. This excludes the patient with disseminated disease (Stage Ill E or IV) since the
extranodal component is most likely a manifestation of dissemination rather than the primary site of
lymphorna. The most common extranodal sites are the stomach and intestinal lining, but lymphomas
have been repeated to originate in all anatomic sites, including thyroid, brain, ocular region, salivary
glands, testis, ovary, central nervous system, bone, breast, lung and sinonasal area1. Central nervous
system as primary site of lymphoma is an uncommon site and approximately 2% of lyrnphomas
originate in this location2. We present a local profile of CNS non-Hodgkin’s lymphornas which
accounts for approximately 2.2% of the total NHLS.
Materials and Methods 
Patient Population
This was a retrospective study of eleven years duration (from 1986 to 1996) and the data was collected
and analysed from the surgical pathology files reported during this period. Most of the cases (39 cases)
were sent to our laboratory from other hospitals in the city or other parts of the country. so precise
clinical history and follow-np data in these patients were not available.
Histology and Immunohistochem ical Analysis
The histologic features were assessed on hematoxylin and eosin (H&E) stained sections of formalin
fixed, paraffin embedded tissue. Most of the cases were classified and graded according to the Working
Formulation. lmmunoh istochem ical studies were carried out in 24 cases. The remaining cases were
not analyzed phenotypically mainly because of the unavailability of this technique in the earlier part of
the study period. 3-5 p.m-thick sections were cut from the paraffin blocks and mounted on poly-l-lysin
coated slides and then immunostained using a battery of antibodies by peroxidase - antiperoxidase
(PAP) technique. The antibodies used included leucocyte common antigen (LCA), Pan B (CD2O or
L26), Pan T (CD45 RO. UCHL-l), glial fibrillary acidic protein (GFAP), neuron specific enolase
(NSE), S-100 protein and epithelial membrane antigen (EMA). All antibodies were obtained from
Dako Inc., Denmark. Parallel positive and negative controls were also run.
Results 
This was a retrospective study of eleven years duration from 1986 to 1996. The surgical pathology files
were evaluated to compile and analyse the data on CNS lymphomas. As mentioned either the major
part of the biopsy material was received from other hospitals of the city as well as from different parts
of the country, so adequate clinical data was missing in most of our study cases. A total of 43 cases
were reported as central nervous system lymphomas during the period of 11 years. Seventeen cases
were intracranial, while 26 cases were spinal in location. The intracranial tumors included: cereherum
12 cases:
cerebellar and ventricular I case each and 3 cases of unknown site. The spinal lymphomas presented
mostly as extradural or epidural masses with signs and symptoms of spinal cord compression. Ten
cases showed in thoracic location; 2 cases in lumbosacral region and in 14 cases the site was not
mentioned. As 39 cases were outside referrals. it was not possible to identify the primary or secondary
nature of the lymphomas. The results of histologic analysis are summarized in Table 1.
There were 28 males and 13 females with male to female ratio of 2: 1. The age at diagnosis in cases of
brain lymphomas ranged from 2 to 73 years (median 50 years) and in cases of spinal lymphomas
ranged from 5 to 69 ears (median 29 years). Most of the cases of brain lymphomas occurred in 5th and
6th decades (10 cases), while the peak incidence in cases of spinal lymphomas was observed in 2nd to
4th decades (16 cases). Three cases of Hodgkin’ disease, not included in the study group, were also
reported in the spinal location as extradural masses. Immunohistochemical analysis was performed in
24 cases out of which 20 cases were subjected for immuno—phenotyping. In two cases the results were
inconclusive. The results are summarized in Table 2.
Discussion 
Non-Hodgkin’s lymphoma (NHL) is a group of malignant neoplasms, wh ich ususal ly arise in
lymphoid tissues. Approximately 10 to 40% of non-Hodgkin’s lymphomas originate or present in
extranodal locations3-4. The most common extranodal sites are stomach and intestinal tract. NHL
presenting as space occupying lesion in the central nervous system (CNS) is uncommon and accounts
for approximately 2% of extranodal lymphomas2. Over 90% of the intracranial lymphornas are
secondary as a result of extracranial systemic spread5. NHL of the nodal or extranodal, non-CNS type
rarely involves the brain parenchyma; involvement of the CNS when it occurs is usually limited to the
leptorneninges and manifested by the presence of malignant cells in the CSF. The term prirnaty CNS
lymphomas should be reserved for those cases which are restricted at presentation to the brain, spinal
cord or meninges6,7. Patients with primary CNS lymphomas often have multiple tumor masses within
the brain parenchyma and which accounts for less than 1% of intracranial tumors6. According to this
study during the eleven years period (1986-1996), 1177 biopsies of CNS were reported, out of which
937 (80%) cases were diagnosed as CNS neoplasms.
Among CNS neoplasms forty-three cases were non-Hodgkin’s lymphomas making 4.6% of all CNS
neoplasms. The primary or secondary nature of CNS lymphomas could not be established in our series
mainly because of inadequate clinical information, in addition of their features, primary CNS
lymphomas histologically exhibit characteristic perivascular distribution of the tumor cells and the
production of a typical pattern of perivascular reticulin fibres i.e., concenteric cuffs or whorls around
the blood vessels (Figure). 
Very rarely the lymphoma is exclusively intravascular (intravascular lymphomatosis) which is a
systemic neoplasm that often involves the nervous system including progressive neurologic dificits in
the background of undiagnosed or quiscent extranodal NHL8. Lymphoblastic and small non-cleaved
cell lymphornas show the highest probability of secondarily invading the CNS. Large cell lvmphoma
particularly the immunoblastic plasmacytoid type is the most common primary CNS tymphoma; small
lymphocytic lymphoma is being the second most common type’. A large number of cases (3 7%) in our
study belonged to the category of large cell lymphoma according to the classification of Internationa
Working Formulation. Although all ages are involved, the individuals in the sixth decade are most often
affected. In our study spinal lymphomas showed median age of 29 years with peak incidence in 2nd to
4th decades while most of the cases of brain lymphomas affected ‘patients in 5th and 6th decades of
life. There is a male to female ratio of approximately 3:2. In our study the male to female ratio was 2:
1. The primary CNS lymphomas are well known to be associated with immunodeficiency states, both
congenital and acquired. Wiskott-Aldrich syndrome is the best documented example in the congenital
group10. Among the acquired group the occurrence of lymphomas is well documented in organ
transplantation and HIV infection. In one study the development of this complication was seen in 6%
of the cases with the neurologic complications of the acquired irnmunodeficiency syndrome (AIDS)1 .
Cerebrum is the commonest site, however, rarely the brainstem and cerebellum are involved.
Multicentricity is a common feature; the frequency varies according to the different series from 20 to
40%, probably based on the extent and thoroughness of the examination12. Almost all primary CNS
lymphomas are of B-cell origin13.
Comparable to the results mentioned in the published literature, 83% of our cases (15 out of 18 for
which the test was carried out) were B cell lymphomas. Three cases showed T cell phenotype including
one case of lymphoblastic lymphoma. One case was diagnosed as T cell rich B cell lymphoma
(TCRBCL) which is a newly recognized entity and is likely to be confused with Hodgkin’s disease and
peripheral T cell lymphoma13
TCRBCL is regarded as an uncommon variant of diffuse large cell lymphoma according to the new
Revised European American lymphoma (REAL) classification.14.
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